Stool DNA testing for early detection of colorectal cancer: systematic review using the HTA Core Model < sup > ® < /sup > for Rapid Relative Effectiveness Assessment

CONCLUSIONS: ColoAlert® is the only stool DNA test currently sold in Europe and is available at a lower price than Cologuard®, but reliable evidence is lacking. A screening study including the current product version of ColoAlert® and suitable comparators would, therefore, help evaluate the effectiveness of this screening option in a European context.PMID:37426885 | PMC:PMC10326527 | DOI:10.3205/000320

Source: GMS German Medical Science - July 10, 2023 Category: General Medicine Authors: Heidi St ürzlinger Annette Conrads-Frank Alexander Eisenmann Sarah Invansits Beate Jahn Andrej Janzic Marjetka Jelenc Tatja Kostnapfel Simona Mencej Bedrac Nikolai M ühlberger Uwe Siebert Gaby Sroczynski European Network for Health Technology Assessment Source Type: research